AUGTYRO (repotrectinib)
Search documents
UBS Gives Zai Lab (ZLAB) a Buy Rating
Yahoo Finance· 2026-01-09 08:16
Zai Lab Limited (NASDAQ:ZLAB) is one of the 12 Stocks that Will Bounce Back According to Wall Street Analysts. On January 6, UBS initiated coverage on Zai Lab Limited (NASDAQ:ZLAB), giving the stock a Buy rating and setting the price target at $35. The research firm noted that the company is moving beyond its previous focus on China to become a global innovation leader. UBS sees Zai Lab Limited (NASDAQ:ZLAB) as undervalued and pointed out that the market is not fully recognizing the value of its global pi ...